ArticleWiener klinische Wochenschrift2011
Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan.
Christian M Kähler et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2011
this papercites it